It was shown that the anti-epilepsy medicine acetazolamide had no direct effect on BK channels (Moldenhauer et al., 2020), suggesting that BK channels were not the target of these general anti-epilepsy medicines. This evidence concerns the gene KCNMA1 and epilepsy.